摘要
目的分析异烟肼联合地塞米松鞘内注射治疗结核性脑膜炎的临床效果。方法选取我院2014年7月—2016年9月收治的结核性脑膜炎患者70例作为研究对象,按照数字表法分为对照组(n=35,行常规治疗)和治疗组(n=35,行异烟肼联合地塞米松鞘内注射治疗),对比2组治疗效果和预后情况。结果治疗组的治疗总有效率与对照组比较,差异有统计学意义(P<0.05);2组残障率比较,治疗组低于对照组(P<0.05)。结论异烟肼联合地塞米松鞘内注射治疗结核性脑膜炎疗效显著,预后良好。
Objective To analyze the clinical effect of intrathecal injection of isoniazid and dexamethasone in the treatment of tuberculous meningitis. Methods 70 cases of tuberculous meningitis treated in our hospital from July 2014 to September 2016 were selected as the subjects, according to the digital chart method, the patients were divided into control group（n=35, routine treatment） and treatment group（n=35, isoniazid combined with dexamethasone intrathecal injection）, and the therapeutic effect and prognosis of the 2 groups were compared. Results The total effective rate of the treatment group compared with the control group, the difference was statistically significant（P〈0.05）; The rate of disability in the 2 groups was lower than that in the control group（P〈0.05）. Conclusion The efficacy of isoniazid combined with dexamethasone intrathecal injection in the treatment of tuberculous meningitis is significant and the prognosis is good.
出处
《中国继续医学教育》
2017年第18期150-151,共2页
China Continuing Medical Education
关键词
结核性脑膜炎
异烟肼
地塞米松
鞘内注射
tuberculous meningitis
isoniazid
dexamethasone
intrathecal injection
